Biocom

Meet the esteemed speakers who will be sharing their insights on cross-border collaboration at our C-suite series event in South San Francisco on June 3. Learn more and register: bit.ly/3P19ca8

AI, cloud technology and advanced data tools are transforming the future of life science and healthcare. Join our member @Google for two upcoming West Coast events bringing together biotech, healthcare and digital health innovators: June 1 | San Francisco West Coast Bio 2026 Learn more: bit.ly/3R0Aj5P June 4 | San Diego West Coast Healthcare Summit 2026 Register: bit.ly/4uOJbtI

This week in the Bay Area life sciences: @AlamarBio launched a blood‑based pTau217 biomarker program for Alzheimer’s detection; @Corcept reported a two‑year overall survival benefit in a Phase 2 ALS study; @PliantTx dosed the first patient in a Phase 1b trial of PLN‑101095; @UnnatProducts raised $45M in Series B financing. Subscribe: bit.ly/40rlR8a

This week in San Diego life sciences: @HalozymeInc entered a global collaboration and license agreement with Oruka to develop ORKA‑001; @UCSanDiego Extended Studies launched an online pharma clinical, regulatory, and compliance course; @SolutionsRenovo expanded its Lab Asset Management Program to improve biotech uptime. Subscribe: bit.ly/4iqn5b1

Don’t miss the opportunity to participate in the 2026 Life Science Total Rewards Survey. Powered by Marsh McLennan Agency in partnership with Biocom Institute, this 60–75 minute survey is designed to help organizations make smarter compensation and talent decisions across the life science industry. Participating organizations will receive a complimentary copy of the full results after the survey closes. Take the survey before it closes on May 22: bit.ly/48EBZHY Questions or access issues? Contact MW.SurveySupport-HRC@MarshMMA.com

Biocom member @UCSDExtStudies is offering an online Pharma Clinical, Regulatory and Compliance course covering clinical trials, FDA regulations and pharmaceutical compliance. Strengthen your understanding of today’s drug development landscape. Learn more: bit.ly/4uH4woS

Working in transdermal drug delivery, neurology, women's health or rare diseases? Seeking a strategic licensing or partnership opportunity? Applications close Monday, May 25 for the opportunity to participate in1:1 partnering meetings with Noven Pharmaceuticals leadership during Biocom's Partnering Day on June 10 in San Diego. A subsidiary of Hisamitsu Pharmaceutical, Noven Pharmaceuticals is seeking strategic partners for asset licensing, external research agreements and regional partnerships focused on advancing innovative therapies through transdermal drug delivery technologies. Selected applicants will be notified by May 31. Apply here: bit.ly/4d5oV15 #Biocom #Partnering #LifeSciences #Pharma

What are the most common Washington DOSH compliance gaps in lab and biotech environments? Join an upcoming webinar with state and industry experts from Occupational Services to gain practical insight into DOSH requirements, frequent violations and actionable steps to reduce risk and strengthen your safety programs. Learn more and register: bit.ly/48WxeK4

Attention early-stage R&D companies in the Bay Area: @MBCBioLabs is now accepting applications for the 2026 ONO Golden Ticket Competition. Winners receive lab space and mentorship from ONO researchers and business leaders. Applications close June 5. Learn more: bit.ly/4trb4ac

It's #NewMemberMonday! ✨ AltruBio Inc. develops first in class immune modulators to treat diseases driven by immunology and inflammation. 💊 @AzoraTx develops novel clinical stage therapies for serious inflammatory diseases including hidradenitis suppurativa and ulcerative colitis. 🧪 @HygiaReagents manufactures GMP grade reagents, NGS solutions and CDMO style diagnostics to support biotech, pharma and diagnostic partners. 🧠 @Immunicom develops a non drug cancer therapy that harnesses the body’s natural immune system to improve outcomes with fewer side effects. 🔬 @PIHealthSc24325 delivers integrated drug discovery, development and API manufacturing to advance IND ready programs efficiently. 🧬 LSMC operates a scalable sequencing as a service platform that enables diagnostics and genomic initiatives without owning labs.

There’s one week left to apply for the National Cancer Institute's SBIR/STTR STEP Program, designed to help early-stage companies strengthen proposals and increase readiness for non-dilutive federal funding opportunities. Learn how your company can leverage this valuable resource: bit.ly/42jQFc4

This week in Greater Los Angeles life sciences: @AcuraStem launched a European subsidiary in Cyprus; @ArrowheadPharm received a positive CHMP opinion for plozasiran; @GATCHealth published two peer reviewed studies advancing AI driven drug discovery. Subscribe: bit.ly/3WFbOLh

This week in Bay Area life sciences: @EliLillyandCo and @ProfluentBio launched a $2.25B AI driven drug discovery collaboration; @Ohalo expanded crop breeding innovation; @PivotBio opened new crop innovation centers; @Synthekine shared updated STK 012 data in non squamous NSCLC at AACR 2026. Subscribe: bit.ly/40rlR8a

Our member, Celito Tech, is is hosting a networking event at the intersection of life science and tech during Bio-IT World. Connect with leaders across biotech, pharma and life science tech in Boston on May 20. Register to attend: bit.ly/4u0zAAc

This week in San Diego life sciences: @UCSanDiego received a $13M CIRM award to study RNA pollution in neurodegenerative disease; @Crinetics gained European approval for paltusotinib in acromegaly; @KyowaKirin_US and @KuraOncology initiated a Phase 2 trial of ziftomenib in NPM1 mutant AML. Subscribe: bit.ly/4iqn5b1

Our member @digitalsci is introducing Compass, a platform for real-time publication intelligence. Research organizations can track impact, benchmark performance and move beyond manual reporting with one unified tool. Access a 14-day free trial: bit.ly/4uyyA68

In this month's Regulatory & Reimbusement Newsletter: Biocom submitted feedback on the FDA’s Plausible Mechanism Framework; President Trump nominates new CDC director; FDA announces new advancements in clinical trials, and more. Read it here: bit.ly/4sgiDA1

Our member Sapient has launched a Tumor Protein Mapping Platform to advance how researchers characterize human tumor biology. With SurfaceSeek, SignalingSeek, ImmuneSeek and ResistanceSeek, the platform enables multidimensional insights across targets, signaling, immunity and resistance. Explore it: bit.ly/4do0wUm

How do you get deeper insight into mAbs beyond standard analysis? Join our member @IbodyInc2018 and Novalix to explore how advanced mass spectrometry is transforming biologics characterization. Register: bit.ly/48HhqdZ

It's #NewMemberMonday! 🩺 @ImmunoScape engineers cancer therapies that selectively activate and expand tumor targeting immune cells in patients. 💉 @KodiakSciences advances durable eye medicines for common retinal diseases that cause vision loss. 🧠 Caladrix Bio pioneers oral medicines that help the brain clear harmful proteins linked to Alzheimer’s disease. 🩻 Pretika MedTech reimagines connected wound care devices that enable continuous monitoring without removing dressings. 💊 Trethera targets core disease pathways in cancer and autoimmune conditions with a first-in-class oral medicine. 🫀 Vasa Therapeutics combats aging related heart disease, including heart failure and life-threatening arrhythmias.